Haemonetics Corp. buy Barrington Research
Start price
13.02.24
/
50%
€66.00
Target price
13.02.25
€97.90
Performance (%)
6.06%
Price
03.10.24
€70.00
Summary
This prediction is currently active. With a performance of 6.06%, the BUY prediction by Barrington_Research for Haemonetics Corp. is trending in the right direction. This prediction currently runs until 13.02.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Haemonetics Corp. | -1.408% | -1.408% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Barrington_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Barrington_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€88.50
10.05.24
10.05.24
€99.33
10.05.25
10.05.25
-20.90%
03.10.24
03.10.24
Haemonetics Corp.
Start price
Target price
Perf. (%)
€78.50
12.04.24
12.04.24
€98.71
12.04.25
12.04.25
-11.47%
03.10.24
03.10.24
Haemonetics Corp.
Start price
Target price
Perf. (%)
€81.50
03.11.23
03.11.23
€97.80
03.11.24
03.11.24
-14.11%
03.10.24
03.10.24